Compare ODTX & AMRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ODTX | AMRC |
|---|---|---|
| Founded | 2021 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Engineering & Construction |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.0B |
| IPO Year | 2025 | 2010 |
| Metric | ODTX | AMRC |
|---|---|---|
| Price | $16.85 | $20.72 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 12 |
| Target Price | $34.67 | ★ $39.10 |
| AVG Volume (30 Days) | 291.0K | ★ 559.5K |
| Earning Date | 11-04-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.35 |
| Revenue | N/A | ★ $1,769,928,000.00 |
| Revenue This Year | N/A | $10.85 |
| Revenue Next Year | N/A | $8.77 |
| P/E Ratio | ★ N/A | $65.09 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $15.10 | $18.09 |
| 52 Week High | $29.05 | $37.14 |
| Indicator | ODTX | AMRC |
|---|---|---|
| Relative Strength Index (RSI) | 36.09 | 44.56 |
| Support Level | $15.73 | $19.06 |
| Resistance Level | $19.60 | $23.87 |
| Average True Range (ATR) | 1.69 | 2.00 |
| MACD | -0.19 | -0.16 |
| Stochastic Oscillator | 6.10 | 25.49 |
Odyssey Therapeutics Inc is a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases. The Company is developing medicines that are designed to precisely target disease pathology with an initial emphasis on the innate immune system. Its programs include OD-07656, a small molecule scaffolding inhibitor of receptor-interacting protein kinase 2, or RIPK2, a small molecule scaffolding inhibitor of interleukin-1 receptor-associated kinase 4, or IRAK4, and OD-00910, an agonistic protein therapeutic targeting tumor necrosis factor receptor 2, or TNFR2, built from camelid heavy chain variable regions, or VHH, domains.
Ameresco Inc is an energy infrastructure solutions provider dedicated to helping customers reduce costs, enhance resilience, and decarbonize to net zero in the energy transition. Its comprehensive portfolio includes implementing smart energy efficiency solutions, upgrading aging infrastructure, and developing, constructing, and operating distributed energy resources. Its solutions range from upgrades to facility's energy infrastructure to the development, construction and operation of renewable energy plants combined with tailored financial solutions. Its segments include North America Regions, U.S. Federal, Renewable Fuels, Europe, and Others. The majority of the revenue is derived from North America Regions segment.